Literature DB >> 32816878

Rare case of a traumatic myositis ossificans in the tibialis anterior muscle.

Chantal J Nieuwenhuizen1, Peter L J van Veldhoven2, Robert F van Oosterom2.   

Abstract

Athletes involved in contact sports can be diagnosed with traumatic myositis ossificans. Myositis ossificans is characterised by a benign ossifying lesion in soft tissue mass, most commonly preceded by a muscle contusion in the thigh. Despite the fact that it is often a self-limiting disease, treatment modalities are anti-inflammatory drugs, physiotherapy, shockwave therapy, radiation therapy or surgical resection. We report a 22-year-old competitive football player with severe ongoing pain in the lower leg after a direct trauma. An X-ray showed calcification between the tibia and fibula. An additional ultrasound confirmed the diagnosis: myositis ossificans of the tibialis anterior muscle. After treating him with anti-inflammatory drugs and physiotherapy, he was able to return to sports. Myositis ossificans of the lower leg is an uncommon, though if present, troublesome condition, occurring after a contusion. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  accidents, injuries; musculoskeletal and joint disorders; orthopaedics; physiotherapy (sports medicine); sports and exercise medicine

Mesh:

Substances:

Year:  2020        PMID: 32816878      PMCID: PMC7437691          DOI: 10.1136/bcr-2019-233210

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  35 in total

Review 1.  Efficacy of Nonsteroidal Anti-inflammatory Drug Prophylaxis for Heterotrophic Ossification in Hip Arthroscopy: A Systematic Review.

Authors:  Marco Yeung; Sahab Jamshidi; Nolan Horner; Nicole Simunovic; Jon Karlsson; Olufemi R Ayeni
Journal:  Arthroscopy       Date:  2015-10-01       Impact factor: 4.772

2.  Myositis ossificans: a case report.

Authors:  Andrew E Hendifar; Dorothy Johnson; Daniel G Arkfeld
Journal:  Arthritis Rheum       Date:  2005-10-15

3.  Myositis ossificans: calcification of the entire tibialis anterior after ischaemic injury (compartment syndrome).

Authors:  N Hyder; D L Shaw; S R Bollen
Journal:  J Bone Joint Surg Br       Date:  1996-03

4.  Treatment of post-traumatic myositis ossificans of the anterior thigh with extracorporeal shock wave therapy.

Authors:  David Allen Torrance; Christopher Degraauw
Journal:  J Can Chiropr Assoc       Date:  2011-12

5.  Heterotopic ossification is less after THA in patients who receive aspirin compared to coumadin.

Authors:  Randy M Cohn; Alejandro González Della Valle; Charles N Cornell
Journal:  Bull NYU Hosp Jt Dis       Date:  2010

6.  Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty.

Authors:  Carlo L Romanò; Dario Duci; Delia Romanò; Mario Mazza; Enzo Meani
Journal:  J Arthroplasty       Date:  2004-01       Impact factor: 4.757

7.  Traumatic myositis ossificans as a result of college fraternity hazing.

Authors:  Jeffrey F Sodl; Rocco Bassora; G Russell Huffman; Mary Ann E Keenan
Journal:  Clin Orthop Relat Res       Date:  2008-01-03       Impact factor: 4.176

8.  Myositis Ossificans of the Temporalis Muscle.

Authors:  Otávio Emmel Becker; Rafael Linard Avelar; Elena Riet Correa Rivero; Rogério Belle De Oliveira; Maria Inês Meurer; Aira Maria Bonfim Santos; Orion Luis Haas Júnior; Eduardo Meurer
Journal:  Head Neck Pathol       Date:  2015-12-24

9.  Myositis ossificans traumatica.

Authors:  J J Danchik; T R Yochum; D D Aspegren
Journal:  J Manipulative Physiol Ther       Date:  1993 Nov-Dec       Impact factor: 1.437

Review 10.  Fibrodysplasia ossificans progressiva: clinical and genetic aspects.

Authors:  Robert J Pignolo; Eileen M Shore; Frederick S Kaplan
Journal:  Orphanet J Rare Dis       Date:  2011-12-01       Impact factor: 4.123

View more
  1 in total

1.  Giant nontraumatic myositis ossificans in a child: A case report.

Authors:  An-Ning Xia; Jiang-Sheng Wang
Journal:  World J Clin Cases       Date:  2022-03-26       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.